| 1 |
35082297 | Low CCR5 expression protects HIV-specific CD4+ T cells of elite controllers from viral entry. | 2022 Jan 26 |
2 |
| 2 |
35231604 | Env-independent protection of intrarectal SIV challenge by vaccine induction of Gag/Vif-specific CD8+ T cells but not CD4+ T cells. | 2022 May 4 |
1 |
| 3 |
33923025 | Stem Cell-Derived Viral Antigen-Specific T Cells Suppress HIV Replication and PD-1 Expression on CD4+ T Cells. | 2021 Apr 25 |
1 |
| 4 |
31889024 | Impact of Early Antiretroviral Therapy Initiation on HIV-Specific CD4 and CD8 T Cell Function in Perinatally Infected Children. | 2020 Feb 1 |
1 |
| 5 |
32462053 | Preclinical Development and Clinical-Scale Manufacturing of HIV Gag-Specific, LentivirusModified CD4 T Cells for HIV Functional Cure. | 2020 Jun 12 |
3 |
| 6 |
33328567 | Mucosal IL-4R antagonist HIV vaccination with SOSIP-gp140 booster can induce high-quality cytotoxic CD4+/CD8+ T cells and humoral responses in macaques. | 2020 Dec 16 |
1 |
| 7 |
30921340 | Induction and maintenance of bi-functional (IFN-γ + IL-2+ and IL-2+ TNF-α+) T cell responses by DNA prime MVA boosted subtype C prophylactic vaccine tested in a Phase I trial in India. | 2019 |
1 |
| 8 |
31216050 | T cell functionality in HIV-1, HIV-2 and dually infected individuals: correlates of disease progression and immune restoration. | 2019 Nov |
1 |
| 9 |
30564243 | Increased Expression of sST2 in Early HIV Infected Patients Attenuated the IL-33 Induced T Cell Responses. | 2018 |
1 |
| 10 |
26537682 | A Subset of CD4/CD8 Double-Negative T Cells Expresses HIV Proteins in Patients on Antiretroviral Therapy. | 2015 Nov 4 |
2 |
| 11 |
26656715 | HIV-1 Antibody Neutralization Breadth Is Associated with Enhanced HIV-Specific CD4+ T Cell Responses. | 2015 Dec 9 |
4 |
| 12 |
24416431 | A parameter for IL-10 and TGF-ß mediated regulation of HIV-1 specific T cell activation provides novel information and relates to progression markers. | 2014 |
1 |
| 13 |
24429370 | Adenovirus serotype 26 and 35 vectors induce simian immunodeficiency virus-specific T lymphocyte responses in foreskin in rhesus monkeys. | 2014 Apr |
1 |
| 14 |
24741089 | Induction of Gag-specific CD4 T cell responses during acute HIV infection is associated with improved viral control. | 2014 Jul |
3 |
| 15 |
23140171 | Targeting of conserved gag-epitopes in early HIV infection is associated with lower plasma viral load and slower CD4(+) T cell depletion. | 2013 Mar |
1 |
| 16 |
23374084 | HIV-specific T-cell responses detected in the genital tract of chronically HIV-infected women are largely monofunctional. | 2013 Jul |
1 |
| 17 |
23616666 | Early Gag immunodominance of the HIV-specific T-cell response during acute/early infection is associated with higher CD8+ T-cell antiviral activity and correlates with preservation of the CD4+ T-cell compartment. | 2013 Jul |
1 |
| 18 |
22031937 | HIV-specific CD4 T cell responses to different viral proteins have discordant associations with viral load and clinical outcome. | 2012 Jan |
1 |
| 19 |
22580564 | Single-cell level response of HIV-specific and cytomegalovirus-specific CD4 T cells correlate with viral control in chronic HIV-1 subtype A infection. | 2012 Sep 1 |
1 |
| 20 |
22911005 | Directly infected resting CD4+T cells can produce HIV Gag without spreading infection in a model of HIV latency. | 2012 |
1 |
| 21 |
23131037 | CD8+ and CD4+ cytotoxic T cell escape mutations precede breakthrough SIVmac239 viremia in an elite controller. | 2012 Nov 6 |
2 |
| 22 |
21159859 | Cell-associated viral burden provides evidence of ongoing viral replication in aviremic HIV-2-infected patients. | 2011 Mar |
1 |
| 23 |
21467219 | Immunization with HIV Gag targeted to dendritic cells followed by recombinant New York vaccinia virus induces robust T-cell immunity in nonhuman primates. | 2011 Apr 26 |
1 |
| 24 |
21505295 | CD4+ T-cell differentiation, regulatory T cells and gag-specific T lymphocytes are unaffected by CD4-guided treatment interruption and therapy resumption. | 2011 Jul 31 |
2 |
| 25 |
20179574 | Cytotoxic granule release dominates gag-specific CD4+ T-cell response in different phases of HIV infection. | 2010 Apr 24 |
2 |
| 26 |
20531016 | Pseudovirion particles bearing native HIV envelope trimers facilitate a novel method for generating human neutralizing monoclonal antibodies against HIV. | 2010 Jul |
1 |
| 27 |
19352428 | Immunodominant HIV-1 Cd4+ T cell epitopes in chronic untreated clade C HIV-1 infection. | 2009 |
6 |
| 28 |
19428572 | A model for testing the immunogenicity of simian immunodeficiency virus and simian-human immunodeficiency virus vaccine candidates in mice. | 2009 Jun |
1 |
| 29 |
19478057 | Gag- and Nef-specific CD4+ T cells recognize and inhibit SIV replication in infected macrophages early after infection. | 2009 Jun 16 |
1 |
| 30 |
18284325 | Detection of HIV type 1 gag-specific CD4(+) T cell responses in acutely infected infants. | 2008 Feb |
1 |
| 31 |
18360285 | Host CCL3L1 gene copy number in relation to HIV-1-specific CD4+ and CD8+ T-cell responses and viral load in South African women. | 2008 Jul 1 |
2 |
| 32 |
18525269 | HIV Gag-specific immune responses predict the rate of CD4 decline. | 2008 Jun 19 |
2 |
| 33 |
18974782 | Magnitude and complexity of rectal mucosa HIV-1-specific CD8+ T-cell responses during chronic infection reflect clinical status. | 2008 |
2 |
| 34 |
17615585 | Robust CD4+ and CD8+ T cell responses to SIV using mRNA-transfected DC expressing autologous viral Ag. | 2007 Aug |
2 |
| 35 |
17881456 | Human immunodeficiency virus-specific CD8+ T-cell activity is detectable from birth in the majority of in utero-infected infants. | 2007 Dec |
1 |
| 36 |
16763520 | Correlation between gag-specific CD8 T-cell responses, viral load, and CD4 count in HIV-1 infection is dependent on disease status. | 2006 Jul |
1 |
| 37 |
16831093 | New CD4+ and CD8+ T cell responses induced in chronically HIV type-1-infected patients after immunizations with an HIV type 1 lipopeptide vaccine. | 2006 Jul |
1 |
| 38 |
16910828 | Immunological and virological effects of structured treatment interruptions following exposure to hydroxyurea plus didanosine. | 2006 Aug |
1 |
| 39 |
16971807 | Simultaneous activation of viral antigen-specific memory CD4+ and CD8+ T-cells using mRNA-electroporated CD40-activated autologous B-cells. | 2006 Sep-Oct |
1 |
| 40 |
15644496 | Glycosaminoglycans and protein disulfide isomerase-mediated reduction of HIV Env. | 2005 Apr |
1 |
| 41 |
15990567 | Analysis of the effect of highly active antiretroviral therapy during acute HIV-1 infection on HIV-specific CD4 T cell functions. | 2005 Jul 22 |
1 |
| 42 |
16123674 | Persistent anti-gag, -Nef, and -Rev IgM levels as markers of the impaired functions of CD4+ T-helper lymphocytes during SIVmac251 infection of cynomolgus macaques. | 2005 Sep 1 |
1 |
| 43 |
16131312 | In HIV type 1-infected children cytotoxic T lymphocyte responses are associated with greater reduction of viremia under antiretroviral therapy. | 2005 Aug |
1 |
| 44 |
15984338 | Cytotoxic T lymphocytes in protection against equine infectious anemia virus. | 2004 Dec |
1 |
| 45 |
12682278 | HIV-specific CD8+ T cell function in children with vertically acquired HIV-1 infection is critically influenced by age and the state of the CD4+ T cell compartment. | 2003 Apr 15 |
1 |
| 46 |
14632751 | CD4 responses to conserved HIV-1 T helper epitopes show both negative and positive associations with virus load in chronically infected subjects. | 2003 Dec |
1 |
| 47 |
12444145 | Presence of HIV-1 Gag-specific IFN-gamma+IL-2+ and CD28+IL-2+ CD4 T cell responses is associated with nonprogression in HIV-1 infection. | 2002 Dec 1 |
2 |
| 48 |
10884430 | Genetically modified anthrax lethal toxin safely delivers whole HIV protein antigens into the cytosol to induce T cell immunity. | 2000 Jul 5 |
2 |
| 49 |
10907641 | Dominant expansion of human T cells in non-obese diabetic/severe combined immunodeficiency mice implanted with human bone fragments. | 2000 Jul |
1 |
| 50 |
10600606 | Glycans and proteoglycans are involved in the interactions of human immunodeficiency virus type 1 envelope glycoprotein and of SDF-1alpha with membrane ligands of CD4(+) CXCR4(+) cells. | 1999 Dec 20 |
1 |